Cargando…
Summary report of the Standards, Options and Recommendations for the use of serum tumour markers in breast cancer: 2000
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2003
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2752999/ https://www.ncbi.nlm.nih.gov/pubmed/12915901 http://dx.doi.org/10.1038/sj.bjc.6601082 |
| _version_ | 1782172320065912832 |
|---|---|
| author | Basuyau, J P Blanc-Vincent, M P Bidart, J M Daver, A Deneux, L Eche, N Gory-Delabaere, G Pichon, M F Riedinger, J M |
| author_facet | Basuyau, J P Blanc-Vincent, M P Bidart, J M Daver, A Deneux, L Eche, N Gory-Delabaere, G Pichon, M F Riedinger, J M |
| author_sort | Basuyau, J P |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-2752999 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2003 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-27529992009-09-28 Summary report of the Standards, Options and Recommendations for the use of serum tumour markers in breast cancer: 2000 Basuyau, J P Blanc-Vincent, M P Bidart, J M Daver, A Deneux, L Eche, N Gory-Delabaere, G Pichon, M F Riedinger, J M Br J Cancer Practice Guideline Nature Publishing Group 2003-08 2003-08-15 /pmc/articles/PMC2752999/ /pubmed/12915901 http://dx.doi.org/10.1038/sj.bjc.6601082 Text en Copyright © 2003 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Practice Guideline Basuyau, J P Blanc-Vincent, M P Bidart, J M Daver, A Deneux, L Eche, N Gory-Delabaere, G Pichon, M F Riedinger, J M Summary report of the Standards, Options and Recommendations for the use of serum tumour markers in breast cancer: 2000 |
| title | Summary report of the Standards, Options and Recommendations for the use of serum tumour markers in breast cancer: 2000 |
| title_full | Summary report of the Standards, Options and Recommendations for the use of serum tumour markers in breast cancer: 2000 |
| title_fullStr | Summary report of the Standards, Options and Recommendations for the use of serum tumour markers in breast cancer: 2000 |
| title_full_unstemmed | Summary report of the Standards, Options and Recommendations for the use of serum tumour markers in breast cancer: 2000 |
| title_short | Summary report of the Standards, Options and Recommendations for the use of serum tumour markers in breast cancer: 2000 |
| title_sort | summary report of the standards, options and recommendations for the use of serum tumour markers in breast cancer: 2000 |
| topic | Practice Guideline |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2752999/ https://www.ncbi.nlm.nih.gov/pubmed/12915901 http://dx.doi.org/10.1038/sj.bjc.6601082 |
| work_keys_str_mv | AT basuyaujp summaryreportofthestandardsoptionsandrecommendationsfortheuseofserumtumourmarkersinbreastcancer2000 AT blancvincentmp summaryreportofthestandardsoptionsandrecommendationsfortheuseofserumtumourmarkersinbreastcancer2000 AT bidartjm summaryreportofthestandardsoptionsandrecommendationsfortheuseofserumtumourmarkersinbreastcancer2000 AT davera summaryreportofthestandardsoptionsandrecommendationsfortheuseofserumtumourmarkersinbreastcancer2000 AT deneuxl summaryreportofthestandardsoptionsandrecommendationsfortheuseofserumtumourmarkersinbreastcancer2000 AT echen summaryreportofthestandardsoptionsandrecommendationsfortheuseofserumtumourmarkersinbreastcancer2000 AT gorydelabaereg summaryreportofthestandardsoptionsandrecommendationsfortheuseofserumtumourmarkersinbreastcancer2000 AT pichonmf summaryreportofthestandardsoptionsandrecommendationsfortheuseofserumtumourmarkersinbreastcancer2000 AT riedingerjm summaryreportofthestandardsoptionsandrecommendationsfortheuseofserumtumourmarkersinbreastcancer2000 |